BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38374278)

  • 1. Synaptic dysfunction and extracellular matrix dysregulation in dopaminergic neurons from sporadic and E326K-GBA1 Parkinson's disease patients.
    Rosh I; Tripathi U; Hussein Y; Rike WA; Djamus J; Shklyar B; Manole A; Houlden H; Winkler J; Gage FH; Stern S
    NPJ Parkinsons Dis; 2024 Feb; 10(1):38. PubMed ID: 38374278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson's disease patients.
    Stern S; Lau S; Manole A; Rosh I; Percia MM; Ben Ezer R; Shokhirev MN; Qiu F; Schafer S; Mansour AA; Mangan KP; Stern T; Ofer P; Stern Y; Diniz Mendes AP; Djamus J; Moore LR; Nayak R; Laufer SH; Aicher A; Rhee A; Wong TL; Nguyen T; Linker SB; Winner B; Freitas BC; Jones E; Sagi I; Bardy C; Brice A; Winkler J; Marchetto MC; Gage FH
    NPJ Parkinsons Dis; 2022 Aug; 8(1):103. PubMed ID: 35948563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulated ECM genes and increased synaptic activity in Parkinson's human DA neurons with PINK1/ PRKN mutations.
    Tripathi U; Rosh I; Ben Ezer R; Nayak R; Hussein Y; Choudhary A; Djamus J; Manole A; Houlden H; Gage FH; Stern S
    NPJ Parkinsons Dis; 2024 May; 10(1):103. PubMed ID: 38762512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking
    Kweon SH; Ryu HG; Park H; Lee S; Kim N; Kwon SH; Ma SX; Kim S; Ko HS
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acid ceramidase involved in pathogenic cascade leading to accumulation of α-synuclein in iPSC model of GBA1-associated Parkinson's disease.
    Kumar M; Srikanth MP; Deleidi M; Hallett PJ; Isacson O; Feldman RA
    Hum Mol Genet; 2023 May; 32(11):1888-1900. PubMed ID: 36752535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deregulation of mTORC1-TFEB axis in human iPSC model of
    Mubariz F; Saadin A; Lingenfelter N; Sarkar C; Banerjee A; Lipinski MM; Awad O
    Front Neurosci; 2023; 17():1152503. PubMed ID: 37332877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secretome Analyses Identify FKBP4 as a
    Kojima R; Paslawski W; Lyu G; Arenas E; Zhang X; Svenningsson P
    Int J Mol Sci; 2024 Jan; 25(1):. PubMed ID: 38203854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging and genetics in Parkinson's disease: assessment of the GBA1 mutation.
    Ghatti S; Yoon E; Lopez G; Ehrlich D; Horovitz SG
    J Neurol; 2022 Oct; 269(10):5347-5355. PubMed ID: 35604467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands.
    den Heijer JM; Cullen VC; Quadri M; Schmitz A; Hilt DC; Lansbury P; Berendse HW; van de Berg WDJ; de Bie RMA; Boertien JM; Boon AJW; Contarino MF; van Hilten JJ; Hoff JI; van Mierlo T; Munts AG; van der Plas AA; Ponsen MM; Baas F; Majoor-Krakauer D; Bonifati V; van Laar T; Groeneveld GJ
    Mov Disord; 2020 Sep; 35(9):1667-1674. PubMed ID: 32618053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease.
    Duran R; Mencacci NE; Angeli AV; Shoai M; Deas E; Houlden H; Mehta A; Hughes D; Cox TM; Deegan P; Schapira AH; Lees AJ; Limousin P; Jarman PR; Bhatia KP; Wood NW; Hardy J; Foltynie T
    Mov Disord; 2013 Feb; 28(2):232-236. PubMed ID: 23225227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of dopamine in the pathogenesis of GBA1-linked Parkinson's disease.
    Burbulla LF; Krainc D
    Neurobiol Dis; 2019 Dec; 132():104545. PubMed ID: 31351996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic mRNA-based differentiation method enables early detection of Parkinson's phenotypes in neurons derived from Gaucher disease-induced pluripotent stem cells.
    Akiyama T; Sato S; Ko SBH; Sano O; Sato S; Saito M; Nagai H; Ko MSH; Iwata H
    Stem Cells Transl Med; 2021 Apr; 10(4):572-581. PubMed ID: 33342090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermal Phospho-Alpha-Synuclein Deposition in Patients With Parkinson's Disease and Mutation of the Glucocerebrosidase Gene.
    Doppler K; Brockmann K; Sedghi A; Wurster I; Volkmann J; Oertel WH; Sommer C
    Front Neurol; 2018; 9():1094. PubMed ID: 30619053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson's disease.
    Krauskopf J; Eggermont K; Madeiro Da Costa RF; Bohler S; Hauser D; Caiment F; de Kok TM; Verfaillie C; Kleinjans JC
    Mol Psychiatry; 2022 Oct; 27(10):4355-4367. PubMed ID: 35725899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A modulator of wild-type glucocerebrosidase improves pathogenic phenotypes in dopaminergic neuronal models of Parkinson's disease.
    Burbulla LF; Jeon S; Zheng J; Song P; Silverman RB; Krainc D
    Sci Transl Med; 2019 Oct; 11(514):. PubMed ID: 31619543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease in a dish - Using stem cells as a molecular tool.
    Badger JL; Cordero-Llana O; Hartfield EM; Wade-Martins R
    Neuropharmacology; 2014 Jan; 76 Pt A():88-96. PubMed ID: 24035919
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Granek Z; Barczuk J; Siwecka N; Rozpędek-Kamińska W; Kucharska E; Majsterek I
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Rab Proteins in Parkinson's Disease Synaptopathy.
    Bellucci A; Longhena F; Spillantini MG
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients.
    Fernández-Santiago R; Carballo-Carbajal I; Castellano G; Torrent R; Richaud Y; Sánchez-Danés A; Vilarrasa-Blasi R; Sánchez-Pla A; Mosquera JL; Soriano J; López-Barneo J; Canals JM; Alberch J; Raya Á; Vila M; Consiglio A; Martín-Subero JI; Ezquerra M; Tolosa E
    EMBO Mol Med; 2015 Dec; 7(12):1529-46. PubMed ID: 26516212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
    Goldstein O; Gana-Weisz M; Cohen-Avinoam D; Shiner T; Thaler A; Cedarbaum JM; John S; Lalioti M; Gurevich T; Bar-Shira A; Mirelman A; Giladi N; Orr-Urtreger A
    Mol Genet Metab; 2019 Dec; 128(4):470-475. PubMed ID: 31662221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.